Â© 2000-2023 QIAGEN. All rights reserved.

Symbol	Entrez Gene Name	GenPept/UniProt/Swiss-Prot Accession	Expr Intensity/RPKM/FPKM/Counts	Expected	Location	Type(s)	Biomarker Application(s)	Drug(s)	Entrez Gene ID for Human	Entrez Gene ID for Mouse	Entrez Gene ID for Rat
AMBRA1	autophagy and beclin 1 regulator 1	Q9C0C7	7518.310	Up	Cytoplasm	other			55626	228361	59319
ATF2	activating transcription factor 2	P15336	6047.230	Up	Nucleus	transcription regulator	prognosis		1386	11909	81647
ATG12	autophagy related 12	O94817	1920.050	Up	Cytoplasm	other			9140	67526	361321
ATG14	autophagy related 14	Q6ZNE5	3348.150	Up	Cytoplasm	other			22863	100504663	305831
BAD	BCL2 associated agonist of cell death	Q92934	6319.190	Up	Cytoplasm	other	efficacy		572	12015	64639
BCL2	BCL2 apoptosis regulator	P10415	2243.060	Down	Cytoplasm	transporter	diagnosis,efficacy,prognosis,unspecified application	(-)-gossypol,ABBV-453,ABBV-623,ABT-737,afatinib/paclitaxel,AZD0466,BCL-2 blocker,BCL201,BGB-11417,bortezomib/paclitaxel,BP1002,chelerythrine,decitabine/venetoclax,doxorubicin/lapatinib/paclitaxel/trastuzumab,doxorubicin/paclitaxel,epirubicin/paclitaxel,everolimus/paclitaxel,FCN-338,gemcitabine/paclitaxel,lapatinib/paclitaxel,levodopa/rasagiline,lisaftoclax,LP-108,LP-118,navitoclax,obatoclax,obinutuzumab/venetoclax,oblimersen,paclitaxel,paclitaxel/pembrolizumab,paclitaxel/pembrolizumab/ramucirumab,paclitaxel/pertuzumab/trastuzumab,paclitaxel/ramucirumab,paclitaxel/rituximab,paclitaxel/topotecan,paclitaxel/trastuzumab,pelcitoclax,rasagiline,rituximab/venetoclax,rosomidnar,S65487,SPC2996,TQB3909,venetoclax,ZN-d5	596	12043	24224
CAMKK2	calciumcalmodulin dependent protein kinase kinase 2	Q96RR4	8138.240	Up	Cytoplasm	kinase			10645	207565	83506
CREB5	cAMP responsive element binding protein 5	Q02930	2077.050	Up	Nucleus	transcription regulator			9586	231991	500131
DDIT3	DNA damage inducible transcript 3	P35638	7850.240	Up	Nucleus	transcription regulator			1649	13198	29467
EIF2AK3	eukaryotic translation initiation factor 2 alpha kinase 3	Q9NZJ5	9237.370	Up	Cytoplasm	kinase	efficacy	GSK2656157,HC-5404-FU,NMS-03597812,SM1-71	9451	13666	29702
EPG5	ectopic P-granules 5 autophagy tethering factor	Q9HCE0	7521.170	Up	Cytoplasm	other			57724	100502841	364902
FOS	Fos proto-oncogene, AP-1 transcription factor subunit	P01100	2618.090	Up	Nucleus	transcription regulator	diagnosis,efficacy		2353	14281	314322
FOXO1	forkhead box O1	Q12778	2440.090	Up	Nucleus	transcription regulator			2308	56458	84482
FOXO3	forkhead box O3	O43524	6608.270	Up	Nucleus	transcription regulator	efficacy		2309	56484	294515
GABARAPL1	GABA type A receptor associated protein like 1	Q9H0R8	8638.230	Up	Cytoplasm	other			23710	57436	689161
INSR	insulin receptor	P06213	8178.260	Down	Plasma Membrane	kinase	prognosis	ABDP,alogliptin/INS,alogliptin/INS/metformin,BMS-536924,BMS-754807,canakinumab/INS,ceritinib,dapagliflozin/INS,dapagliflozin/INS/metformin,dulaglutide/INS,exenatide/INS,exenatide/INS/metformin,exenatide/INS/metformin/pioglitazone,exenatide/INS/pioglitazone,GSK1838705A,GSK1904529A,INS,INS/linagliptin,INS/linagliptin/metformin,INS/lixisenatide,INS/metformin,INS/metformin/pioglitazone,INS/metformin/saxagliptin,INS/metformin/sitagliptin,INS/metformin/vildagliptin,INS/pioglitazone,INS/protamine zinc insulin,INS/saxagliptin,INS/sitagliptin,INS/vildagliptin,insulin aspart,insulin aspart/insulin degludec,insulin aspart/insulin detemir,insulin degludec,insulin degludec/liraglutide,insulin detemir,insulin glargine,insulin glargine/insulin lispro,insulin glargine/lixisenatide,insulin glargine/lixisenatide/metformin,insulin glargine/metformin,insulin glargine/metformin/sulfonylurea,insulin glulisine,insulin lispro,KW-2450,protamine zinc insulin,SM1-71,staurosporine,subetta	3643	16337	24954
JUN	Jun proto-oncogene, AP-1 transcription factor subunit	P05412	6537.250	Up	Nucleus	transcription regulator	prognosis,unspecified application		3725	16476	24516
KAT5	lysine acetyltransferase 5	Q92993	7207.240	Up	Nucleus	transcription regulator			10524	81601	192218
MYC	MYC proto-oncogene, bHLH transcription factor	P01106	4441.100	Down	Nucleus	transcription regulator	diagnosis,efficacy,prognosis,response to therapy,unspecified application	AVI-4126,MYC-targeting siRNA DCR-MYC,OMO-103,WBC100	4609	17869	24577
MYD88	MYD88 innate immune signal transduction adaptor	Q99836	7085.240	Up	Plasma Membrane	other	efficacy	bazlitoran	4615	17874	301059
NRBF2	nuclear receptor binding factor 2	Q96F24	6176.210	Up	Nucleus	transcription regulator			29982	641340	58839|499670|100363472
PLEKHM1	pleckstrin homology and RUN domain containing M1	Q9Y4G2	3940.200	Up	Cytoplasm	other			9842	353047	303584
PPM1D	protein phosphatase, Mg2+Mn2+ dependent 1D	O15297	5839.160	Up	Cytoplasm	phosphatase			8493	53892	287585
PPM1L	protein phosphatase, Mg2+Mn2+ dependent 1L	Q5SGD2	8011.250	Up	Cytoplasm	phosphatase			151742	242083	310506
PPP2R3B	protein phosphatase 2 regulatory subunit B''beta	Q9Y5P8	2478.120	Up	Nucleus	phosphatase			28227	 	 
PPP2R5B	protein phosphatase 2 regulatory subunit B'beta	Q15173	3748.130	Up	Cytoplasm	phosphatase			5526	225849	309179
PRKAB2	protein kinase AMP-activated non-catalytic subunit beta 2	O43741	6369.190	Up	Cytoplasm	kinase			5565	108097	64562
RB1CC1	RB1 inducible coiled-coil 1	Q8TDY2	10230.300	Up	Nucleus	other			9821	12421	312927
TFEB	transcription factor EB	P19484	6881.180	Up	Nucleus	transcription regulator			7942	21425	316214
TGFB1	transforming growth factor beta 1	P01137	7180.160	Down	Extracellular Space	growth factor	diagnosis,efficacy,prognosis,safety,unspecified application	AVID200,cotsiranib,dalantercept,fresolimumab,HB-002T,LY2109761,LY3200882,MSB0011359C,NIS793,SHR1701,SRK-181,STP707,YL-13027	7040	21803	59086
TNFRSF1A	TNF receptor superfamily member 1A	P19438	856.038	Up	Plasma Membrane	transmembrane receptor	safety,unspecified application	GSK2862277	7132	21937	25625
TRAF6	TNF receptor associated factor 6	Q9Y4K3	9971.380	Up	Cytoplasm	enzyme			7189	22034	311245
ULK1	unc-51 like autophagy activating kinase 1	O75385	4315.160	Up	Cytoplasm	kinase		DCC-3116,MRT68921,SBI-0206965,WZ3105	8408	22241	360827
WIPI1	WD repeat domain, phosphoinositide interacting 1	Q5MNZ9	2438.070	Up	Cytoplasm	other	unspecified application		55062	52639	303630
